13F HOLDINGS REPORT
MIC Capital Management UK LLP
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001085146-25-005259
Total Value
$509.3M
Positions
16
Other Managers
0
Confidential Omitted
No
Holdings (16)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HAYWARD HLDGS INC | HAYW | 10,548,539 | $145.6M | 28.58% |
| 2 | METSERA INC | 59267L107 | 4,539,540 | $129.1M | 25.36% |
| 3 | COUPANG INC | CPNG | 1,412,946 | $42.3M | 8.31% |
| 4 | RECURSION PHARMACEUTICALS IN | RXRX | 7,062,869 | $35.7M | 7.02% |
| 5 | RESTAURANT BRANDS INTL INC | 76131D103 | 386,203 | $25.6M | 5.03% |
| 6 | GRAB HOLDINGS LIMITED | GRABW | 5,000,000 | $25.1M | 4.94% |
| 7 | META PLATFORMS INC | META | 33,300 | $24.6M | 4.83% |
| 8 | MONDAY COM LTD | MNDY | 66,000 | $20.8M | 4.08% |
| 9 | REVOLUTION MEDICINES INC | RVMDW | 508,569 | $18.7M | 3.67% |
| 10 | ALIBABA GROUP HLDG LTD | BBAAY | 150,000 | $17.0M | 3.34% |
| 11 | ARCHER AVIATION INC | ACHR-WT | 700,000 | $7.6M | 1.49% |
| 12 | RECURSION PHARMACEUTICALS IN | RXRX | 1,388,889 | $7.0M | 1.38% |
| 13 | RECURSION PHARMACEUTICALS IN | RXRX | 1,192,274 | $6.0M | 1.18% |
| 14 | NEUMORA THERAPEUTICS INC. | NMRA | 2,230,350 | $1.6M | 0.32% |
| 15 | NEUMORA THERAPEUTICS INC. | NMRA | 2,230,350 | $1.6M | 0.32% |
| 16 | LYELL IMMUNOPHARMA INC | LYEL | 87,028 | $769,328 | 0.15% |